Cases 11 - 20 of 30
Bristol-Myers Squibb Company et al v. Breckenridge Pharmaceutical, Inc.
as 1:2017cv00375
Plaintiff:
Bristol-Myers Squibb Company and Pfizer Inc.
Defendant:
Breckenridge Pharmaceutical, Inc.
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al v. Breckenridge Pharmaceutical, Inc. et al
as 1:2017cv00302
Plaintiff:
Pfizer Inc. , PF Prism C.V. and C.P. Pharmaceuticals International C.V.
Defendant:
Breckenridge Pharmaceutical, Inc., Pensa Pharma S.A. and Laboratorios del Dr. Esteve, S.A.
Cause Of Action: 35 U.S.C. § 271
Sanofi-Aventis U.S. LLC et al v. Breckenridge Pharmaceutical, Inc.
as 1:2017cv00019
Plaintiff:
Sanofi-Aventis U.S. LLC , Aventisub LLC , Sanofi and others
Defendant:
Breckenridge Pharmaceutical, Inc.
Cause Of Action: 35 U.S.C. § 271
Onyx Therapeutics, Inc. v. Breckenridge Pharmaceutical Inc.
as 1:2016cv01001
Plaintiff:
Onyx Therapeutics, Inc.
Defendant:
Breckenridge Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271
Amgen Inc. v. Breckenridge Pharmaceutical Inc.
as 1:2016cv00927
Plaintiff:
Amgen Inc.
Defendant:
Breckenridge Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271
Bayer Intellectual Property GMBH et al v. Breckenridge Pharmaceutical Inc.
as 1:2016cv00628
Plaintiff:
Bayer Intellectual Property GMBH , Bayer Pharma AG and Janssen Pharmaceuticals Inc.
Defendant:
Breckenridge Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation et al v. Breckenridge Pharmaceutical Inc.
as 1:2016cv00431
Plaintiff:
Novartis Pharmaceuticals Corporation and Novartis AG
Defendant:
Breckenridge Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271
OSI Pharmaceuticals, LLC et al v. Breckenridge Pharmaceutical Inc. et al
as 1:2015cv01063
Plaintiff:
OSI Pharmaceuticals, LLC , Pfizer Inc. and Genentech Inc.
Defendant:
Breckenridge Pharmaceutical Inc. and Natco Pharma Ltd.
Cause Of Action: 35 U.S.C. § 271
Par Pharmaceutical Inc. et al v. Breckenridge Pharmaceutical Inc.
as 1:2015cv01039
Plaintiff:
Par Pharmaceutical Inc. and Alkermes Pharma Ireland Limited
Defendant:
Breckenridge Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271
Bayer Intellectual Property GMBH et al v. Aurobindo Pharma Limited et al
as 1:2015cv00902
Plaintiff:
Bayer Intellectual Property GMBH , Bayer Pharma AG and Janssen Pharmaceuticals Inc.
Defendant:
Aurobindo Pharma Limited , Aurobindo Pharma USA Inc. , Breckenridge Pharmaceutical Inc. and others
Counter_claimant:
Sigmapharm Laboratories LLC and Prinston Pharmaceutical Inc.
Counter_defendant:
Bayer Intellectual Property GMBH , Bayer Pharma AG and Janssen Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
